ID   SSR2_RAT                Reviewed;         369 AA.
AC   P30680;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   02-OCT-2024, entry version 178.
DE   RecName: Full=Somatostatin receptor type 2;
DE            Short=SS-2-R;
DE            Short=SS2-R;
DE            Short=SS2R;
DE   AltName: Full=SRIF-1;
GN   Name=Sstr2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=1374909; DOI=10.1073/pnas.89.10.4618;
RA   Kluxen F.-W., Bruns C., Luebbert H.;
RT   "Expression cloning of a rat brain somatostatin receptor cDNA.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:4618-4622(1992).
RN   [2]
RP   PROTEIN SEQUENCE OF 76-81; 179-189; 294-320 AND 350-358.
RC   TISSUE=Pituitary;
RX   PubMed=1348934; DOI=10.1016/0006-291x(92)91168-p;
RA   Hulmes J.D., Corbett M., Zysk J.R., Boehlen P., Eppler C.M.;
RT   "Partial amino acid sequence of a somatostatin receptor isolated from GH4C1
RT   pituitary cells.";
RL   Biochem. Biophys. Res. Commun. 184:131-136(1992).
RN   [3]
RP   FUNCTION, TISSUE SPECIFICITY, AND ALTERNATIVE SPLICING (ISOFORMS A AND B).
RX   PubMed=8386508; DOI=10.1006/bbrc.1993.1412;
RA   Patel Y.C., Greenwood M., Kent G., Panetta R., Srikant C.B.;
RT   "Multiple gene transcripts of the somatostatin receptor SSTR2: tissue
RT   selective distribution and cAMP regulation.";
RL   Biochem. Biophys. Res. Commun. 192:288-294(1993).
RN   [4]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=11134004; DOI=10.1074/jbc.m006084200;
RA   Pfeiffer M., Koch T., Schroder H., Klutzny M., Kirscht S., Kreienkamp H.J.,
RA   Hollt V., Schulz S.;
RT   "Homo- and heterodimerization of somatostatin receptor subtypes.
RT   Inactivation of sst(3) receptor function by heterodimerization with
RT   sst(2A).";
RL   J. Biol. Chem. 276:14027-14036(2001).
RN   [5]
RP   FUNCTION, INTERACTION WITH BETA-ARRESTIN, SUBCELLULAR LOCATION, AND
RP   PHOSPHORYLATION.
RX   PubMed=17981995; DOI=10.1124/mol.107.038570;
RA   Liu Q., Dewi D.A., Liu W., Bee M.S., Schonbrunn A.;
RT   "Distinct phosphorylation sites in the SST2A somatostatin receptor control
RT   internalization, desensitization, and arrestin binding.";
RL   Mol. Pharmacol. 73:292-304(2008).
RN   [6]
RP   PHOSPHORYLATION AT SER-341; SER-343; SER-348; THR-353 AND THR-354.
RX   PubMed=19389921; DOI=10.1124/mol.108.054262;
RA   Liu Q., Bee M.S., Schonbrunn A.;
RT   "Site specificity of agonist and second messenger-activated kinases for
RT   somatostatin receptor subtype 2A (Sst2A) phosphorylation.";
RL   Mol. Pharmacol. 76:68-80(2009).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=19434240; DOI=10.1371/journal.pone.0005509;
RA   Le Verche V., Kaindl A.M., Verney C., Csaba Z., Peineau S., Olivier P.,
RA   Adle-Biassette H., Leterrier C., Vitalis T., Renaud J., Dargent B.,
RA   Gressens P., Dournaud P.;
RT   "The somatostatin 2A receptor is enriched in migrating neurons during rat
RT   and human brain development and stimulates migration and axonal
RT   outgrowth.";
RL   PLoS ONE 4:E5509-E5509(2009).
CC   -!- FUNCTION: Receptor for somatostatin-14 and -28. This receptor is
CC       coupled via pertussis toxin sensitive G proteins to inhibition of
CC       adenylyl cyclase. In addition it stimulates phosphotyrosine phosphatase
CC       and PLC via pertussis toxin insensitive as well as sensitive G
CC       proteins. Inhibits calcium entry by suppressing voltage-dependent
CC       calcium channels. Acts as the functionally dominant somatostatin
CC       receptor in pancreatic alpha- and beta-cells where it mediates the
CC       inhibitory effect of somatostatin-14 on hormone secretion. Inhibits
CC       cell growth through enhancement of MAPK1 and MAPK2 phosphorylation and
CC       subsequent up-regulation of CDKN1B. Stimulates neuronal migration and
CC       axon outgrowth and may participate in neuron development and maturation
CC       during brain development. Mediates negative regulation of insulin
CC       receptor signaling through PTPN6. Inactivates SSTR3 receptor function
CC       following heterodimerization. {ECO:0000269|PubMed:11134004,
CC       ECO:0000269|PubMed:17981995, ECO:0000269|PubMed:19434240,
CC       ECO:0000269|PubMed:8386508}.
CC   -!- SUBUNIT: Homodimer and heterodimer with SSTR3 and SSTR5.
CC       Heterodimerization with SSTR3 inactivates SSTR3 receptor function.
CC       Heterodimerization with SSTR5 is enhanced by agonist stimulation of
CC       SSTR2 and increases SSTR2 cell growth inhibition activity. Following
CC       agonist stimulation, homodimers dissociate into monomers which is
CC       required for receptor internalization. Interacts with beta-arrestin;
CC       this interaction is necessary for receptor internalization and is
CC       destabilized by heterodimerization with SSTR5 which results in
CC       increased recycling of SSTR2 to the cell surface. Interacts (via C-
CC       terminus) with SHANK1 (via PDZ domain). {ECO:0000269|PubMed:11134004,
CC       ECO:0000269|PubMed:17981995}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Cytoplasm. Note=Located mainly at the cell surface under basal
CC       conditions. Agonist stimulation results in internalization to the
CC       cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=A;
CC         IsoId=P30680-1; Sequence=Displayed;
CC       Name=B;
CC         IsoId=P30680-2; Sequence=VSP_001924;
CC   -!- TISSUE SPECIFICITY: Cortex, hippocampus, pituitary gland, colon,
CC       kidney, and adrenal gland. In the developing nervous system, expressed
CC       from E12 when it is restricted to postmitotic neuronal populations
CC       leaving the ventricular zone. From E12 on, expressed in migrating
CC       neuronal populations in numerous developing regions including the
CC       cerebral cortex, hippocampus and ganglionic eminences. Also detected in
CC       the deep part of the external granular layer of the cerebellum, the
CC       rostral migratory stream and a subset of axons and neurons. Expressed
CC       in the medial forebrain bundle, rostral migratory stream and cerebellum
CC       during development but not in adulthood. {ECO:0000269|PubMed:1374909,
CC       ECO:0000269|PubMed:19434240, ECO:0000269|PubMed:8386508}.
CC   -!- PTM: Phosphorylated on serine and threonine residues in response to
CC       agonist stimulation, leading to receptor desensitization and rapid
CC       internalization. Phosphorylated to a greater extent on serine than
CC       threonine residues. Threonine phosphorylation is required for arrestin
CC       binding and receptor endocytosis but is not necessary for
CC       desensitization. {ECO:0000269|PubMed:17981995,
CC       ECO:0000269|PubMed:19389921}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M96817; AAA42166.1; -; mRNA.
DR   EMBL; M93273; AAA42165.1; -; mRNA.
DR   PIR; A45291; A45291.
DR   RefSeq; NP_062221.1; NM_019348.1. [P30680-1]
DR   PDB; 6EXJ; X-ray; 1.80 A; B/D=364-369.
DR   PDBsum; 6EXJ; -.
DR   AlphaFoldDB; P30680; -.
DR   SMR; P30680; -.
DR   BioGRID; 248525; 6.
DR   IntAct; P30680; 1.
DR   MINT; P30680; -.
DR   STRING; 10116.ENSRNOP00000003735; -.
DR   BindingDB; P30680; -.
DR   ChEMBL; CHEMBL2978; -.
DR   DrugCentral; P30680; -.
DR   GuidetoPHARMACOLOGY; 356; -.
DR   GlyCosmos; P30680; 4 sites, No reported glycans.
DR   GlyGen; P30680; 4 sites.
DR   iPTMnet; P30680; -.
DR   PhosphoSitePlus; P30680; -.
DR   PaxDb; 10116-ENSRNOP00000003735; -.
DR   Ensembl; ENSRNOT00000003735.4; ENSRNOP00000003735.3; ENSRNOG00000002793.6. [P30680-2]
DR   Ensembl; ENSRNOT00000116317.1; ENSRNOP00000094133.1; ENSRNOG00000002793.6. [P30680-1]
DR   Ensembl; ENSRNOT00055056666; ENSRNOP00055046772; ENSRNOG00055032775. [P30680-1]
DR   Ensembl; ENSRNOT00060039906; ENSRNOP00060032975; ENSRNOG00060023021. [P30680-1]
DR   Ensembl; ENSRNOT00065032291; ENSRNOP00065025799; ENSRNOG00065019192. [P30680-1]
DR   GeneID; 54305; -.
DR   KEGG; rno:54305; -.
DR   AGR; RGD:3763; -.
DR   CTD; 6752; -.
DR   RGD; 3763; Sstr2.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT00940000156544; -.
DR   HOGENOM; CLU_009579_8_1_1; -.
DR   InParanoid; P30680; -.
DR   OMA; YYDQTSN; -.
DR   OrthoDB; 5393360at2759; -.
DR   PhylomeDB; P30680; -.
DR   TreeFam; TF315737; -.
DR   Reactome; R-RNO-375276; Peptide ligand-binding receptors.
DR   Reactome; R-RNO-418594; G alpha (i) signalling events.
DR   PRO; PR:P30680; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000002793; Expressed in Ammon's horn and 6 other cell types or tissues.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0042923; F:neuropeptide binding; IBA:GO_Central.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:UniProtKB.
DR   GO; GO:0004994; F:somatostatin receptor activity; IDA:RGD.
DR   GO; GO:0007193; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IEP:RGD.
DR   GO; GO:0071385; P:cellular response to glucocorticoid stimulus; IEP:RGD.
DR   GO; GO:0021549; P:cerebellum development; IEP:RGD.
DR   GO; GO:0030900; P:forebrain development; IEP:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0007218; P:neuropeptide signaling pathway; ISO:RGD.
DR   GO; GO:0030432; P:peristalsis; IMP:RGD.
DR   GO; GO:0042594; P:response to starvation; IEP:RGD.
DR   GO; GO:0038170; P:somatostatin signaling pathway; ISO:RGD.
DR   GO; GO:0007283; P:spermatogenesis; IEP:RGD.
DR   CDD; cd15971; 7tmA_SSTR2; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR000586; Somatstn_rcpt.
DR   InterPro; IPR002074; Somatstn_rcpt_2.
DR   PANTHER; PTHR24229; NEUROPEPTIDES RECEPTOR; 1.
DR   PANTHER; PTHR24229:SF6; SOMATOSTATIN RECEPTOR TYPE 2; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR00246; SOMATOSTATNR.
DR   PRINTS; PR00588; SOMATOSTTN2R.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Cytoplasm;
KW   Direct protein sequencing; Disulfide bond; G-protein coupled receptor;
KW   Glycoprotein; Lipoprotein; Membrane; Palmitate; Phosphoprotein; Receptor;
KW   Reference proteome; Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN           1..369
FT                   /note="Somatostatin receptor type 2"
FT                   /id="PRO_0000070123"
FT   TOPO_DOM        1..43
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        44..67
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        68..78
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        79..103
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        104..118
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        119..138
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        139..161
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        162..181
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        182..207
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        208..229
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        230..253
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        254..278
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        279..288
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        289..303
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        304..369
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         341
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:19389921"
FT   MOD_RES         343
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:19389921"
FT   MOD_RES         348
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:19389921"
FT   MOD_RES         353
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:19389921"
FT   MOD_RES         354
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:19389921"
FT   LIPID           328
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        9
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        22
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        29
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        32
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        115..193
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   VAR_SEQ         332..369
FT                   /note="VSGAEDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI -> ADNSKTGEED
FT                   TMAWV (in isoform B)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_001924"
FT   STRAND          365..368
FT                   /evidence="ECO:0007829|PDB:6EXJ"
SQ   SEQUENCE   369 AA;  41200 MW;  4990E489E88D7D19 CRC64;
     MELTSEQFNG SQVWIPSPFD LNGSLGPSNG SNQTEPYYDM TSNAVLTFIY FVVCVVGLCG
     NTLVIYVILR YAKMKTITNI YILNLAIADE LFMLGLPFLA MQVALVHWPF GKAICRVVMT
     VDGINQFTSI FCLTVMSIDR YLAVVHPIKS AKWRRPRTAK MINVAVWGVS LLVILPIMIY
     AGLRSNQWGR SSCTINWPGE SGAWYTGFII YAFILGFLVP LTIICLCYLF IIIKVKSSGI
     RVGSSKRKKS EKKVTRMVSI VVAVFIFCWL PFYIFNVSSV SVAISPTPAL KGMFDFVVIL
     TYANSCANPI LYAFLSDNFK KSFQNVLCLV KVSGAEDGER SDSKQDKSRL NETTETQRTL
     LNGDLQTSI
//
